Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients

Specific sHLA in healthy donors and donor-specific sHLA in renal transplant patients

Autor Borelli, S. D. Google Scholar
Ferreira, E. Google Scholar
Oliveira, A. M. Google Scholar
Krishnaswamy, S. Google Scholar
Hiraki, D. D. Google Scholar
Grumet, F. C. Google Scholar
Instituição Universidade Estadual de Maringá (UEM)
Universidade Federal de São Paulo (UNIFESP)
Stanford Univ
Resumo We studied cadaver kidney transplant recipients to determine if their serum levels of donor-specific class I sHLA correlated with graft outcome. Testing of sHLA was performed by an ELISA sandwich assay using allospecific monoclonal trapping antibodies and anti-beta 2-mu detecting antibody. Sufficient sHLA sensitivity (<1 ng:ml) was achieved by using two synergistic trapping antibodies. Suitable antibodies were available for A2 and B7, and data were collected for these two antigens. Stability of these sHLA was determined in plasma and serum as were ranges of normal and background levels. Background levels varied substantially. Five AZ recipients of A2(+) grafts and 5 B7(-) recipients of B7(+) grafts were studied with appropriate sHLA levels measured pretransplant and at intervals post-transplant. Graft outcome was assessed by serum creatinines? renal biopsies and/or therapy for rejection. in the 5 patients (3 A2(-) and 2 B7(-)) whose post-transplant donor-specific sHLA never exceeded immunological complications (e.g., post-operative ATN, ureteral obstruction) did not affect the correlation. in the 5 patients with post-transplant levels exceeding pre-transplant levels, subsequent evidence of rejection was observed. Periodic measurement of donor-specific sHLA should be a useful instrument for monitoring renal allograft rejection. (C) American Society for Histocompatibility and Immunogenetics, 1999 Published by Elsevier Science Inc.
Palavra-chave soluble HLA
renal transplant
soluble HLA-A2 and HLA-B7
Idioma Inglês
Data de publicação 1999-05-01
Publicado em Human Immunology. New York: Elsevier B.V., v. 60, n. 5, p. 430-434, 1999.
ISSN 0198-8859 (Sherpa/Romeo, fator de impacto)
Publicador Elsevier B.V.
Extensão 430-434
Fonte http://dx.doi.org/10.1016/S0198-8859(99)00012-9
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000080730100008
Endereço permanente http://repositorio.unifesp.br/handle/11600/26074

Exibir registro completo


Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções



Minha conta